Cargando…
Preventing Mortality in COVID-19 Patients: Which Cytokine to Target in a Raging Storm?
Coronavirus disease 2019 (COVID-19) from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in tremendous morbidity and mortality worldwide. A major underlying cause of COVID-19 mortality is a hyperinflammatory cytokine storm in severe/critically ill patients. Althou...
Autores principales: | Lu, Ligong, Zhang, Hui, Zhan, Meixiao, Jiang, Jun, Yin, Hua, Dauphars, Danielle J., Li, Shi-You, Li, Yong, He, You-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7379422/ https://www.ncbi.nlm.nih.gov/pubmed/32766256 http://dx.doi.org/10.3389/fcell.2020.00677 |
Ejemplares similares
-
Antibody response and therapy in COVID-19 patients: what can be learned for vaccine development?
por: Lu, Ligong, et al.
Publicado: (2020) -
The Inhibitory Effect of Curcumin on Virus-Induced Cytokine Storm and Its Potential Use in the Associated Severe Pneumonia
por: Liu, Ziteng, et al.
Publicado: (2020) -
Clinically approved combination immunotherapy: Current status, limitations, and future perspective
por: Lu, Ligong, et al.
Publicado: (2022) -
Enhanced Human T Lymphocyte Antigen Priming by Cytokine-Matured Dendritic Cells Overexpressing Bcl-2 and IL-12
por: Zhang, Hui, et al.
Publicado: (2020) -
The Impact of Diabetic Conditions and AGE/RAGE Signaling on Cardiac Fibroblast Migration
por: Burr, Stephanie D., et al.
Publicado: (2020)